Add BrightSurf on Google Email

Plants uptake antibiotics

Food crops like corn, lettuce, and potato take up antibiotics from soils treated with manure containing the antibiotic Sulfamethazine. This raises concerns about the potential for contamination of the human food supply, particularly among vulnerable populations like young children who may experience allergic reactions.

SourceSoil Science Society of America·JournalJournal of Environmental Quality·DateJul 11, 2007

Scripps/UC San Diego scientists solve genome of promising marine organism

Researchers have successfully sequenced the genome of Salinispora tropica, a bacterium discovered in Bahamian mud with potential to produce compounds showing promise in treating diseases such as cancer. The decoded genome reveals an impressive 10% of genes dedicated to producing molecules for antibiotics and anticancer agents.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateJun 13, 2007

New guideline for treating Lyme disease

The American Academy of Neurology has published a new guideline for treating Lyme disease affecting the nervous system, finding conventional antibiotic courses highly effective. Prolonged antibiotic treatment does not improve outcomes for patients with persistent symptoms after standard therapy.

SourceAmerican Academy of Neurology·JournalNeurology·DateMay 23, 2007

Arming the fight against resistant bacteria

Researchers at University of Wisconsin-Madison have devised a method to tackle antibiotic resistance, identifying four promising new compounds with preliminary antibacterial activity. The compounds show promise against MRSA and other Gram-positive bacteria, but further research is needed to understand their mechanism of action.

SourceUniversity of Wisconsin-Madison·JournalChemistry & Biology·DateApr 27, 2007

Will the plague pathogen become resistant to antibiotics?

Researchers have found the same plasmids responsible for antibiotic resistance in common bacteria also present in the plague bacillus Yersinia pestis, raising concerns about its potential spread. This discovery highlights a significant public health risk as MDR Y. pestis could rapidly evolve and affect human health.

SourcePLOS·JournalPLOS ONE·DateMar 20, 2007

Why is long-term therapy required to cure tuberculosis?

TB patients must take long-term therapy due to a correlation between bacterial burden and time to cure. Researchers suggest that non-replicating bacteria are not TB-specific and that understanding this phenomenon can lead to shorter treatment durations for recalcitrant bacterial infections.

SourcePLOS·JournalPLOS Medicine·DateMar 19, 2007

Antibiotics appear to be overprescribed for sinus infections

A recent study found that antibiotics are prescribed for approximately 82% of acute and chronic sinus infections, despite viruses being the most frequent cause. This overprescription has significant concerns, including drug resistance and virulent bacteria, as well as increased healthcare costs.

SourceJAMA Network·JournalArchives of Otolaryngology - Head and Neck Surgery·DateMar 19, 2007

Gallium: A new antibacterial agent?

Researchers at the University of Washington discovered that Gallium inhibits the growth of Pseudomonas aeruginosa and prevents biofilm formation, offering a potential therapeutic solution for cystic fibrosis patients. Inhalation of Gallium also protected mice from P. aeruginosa lung infections.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 15, 2007

Bacterial walls come tumbling down

Scientists have detailed images of a bacterial cell wall target that could aid in designing new antibiotics to treat deadly infections. The images, published in the journal Science, show an antibiotic called moenomycin binding to the enzyme, providing a new understanding of its structure and function.

SourceHoward Hughes Medical Institute·JournalScience·DateMar 9, 2007

Bioengineering efficient antibiotic biosynthesis in E. coli

Researchers used bioassay-guided evolution to identify more efficient antibiotic-producing mutants in Escherichia coli, reconstituting the biosynthetic pathways of sugars to yield a new antibiotic. This approach opens doors for harnessing genetics to investigate polyketide synthases and biosynthetic engineering.

SourcePLOS·JournalPLOS Biology·DateFeb 5, 2007

Joining forces

Researchers at the Weizmann Institute have designed a more powerful weapon to fight bacteria by combining key properties of antimicrobial peptides and lipopeptides. The new synthetic peptides exhibit both positive charge and soap-like ability to dissolve oils, targeting a range of bacterial and fungal infections.

SourceAmerican Committee for the Weizmann Institute of Science·JournalProceedings of the National Academy of Sciences·DateDec 28, 2006

First Laos bacteraemia study highlights need for local knowledge

The study reveals that Salmonella enterica serovar typhi is the most common cause of bacteraemia in children and adults, with almost half of all cases found in children. Local knowledge is crucial for developing effective public health interventions, particularly in a resource-constrained healthcare system.

SourceWellcome Trust·JournalAmerican Journal of Tropical Medicine and Hygiene·DateDec 14, 2006

Evolution of typhoid bacteria

The study reveals that asymptomatic carriers played a crucial role in the evolution and global transmission of Typhi, leading to antibiotic resistance and hindering treatment efforts. The research also highlights the importance of healthy carriers in facilitating the spread of the bacteria.

SourceMax-Planck-Gesellschaft·JournalScience·DateNov 28, 2006

Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia

Scientists have discovered that the Chlamydia bacterium shares a common ancestry with plants, which could lead to the development of an effective new treatment for chlamydia. The discovery highlights similarities in genetic sequences and functions between the two organisms, providing a potential target for antibiotics.

SourceRutgers University·JournalProceedings of the National Academy of Sciences·DateNov 7, 2006

Killing resistant germs

Researchers have successfully synthesized platensimycin, a new antibiotic that inhibits bacterial fatty acid biosynthesis and paralyzes Gram-positive bacterial strains. This breakthrough offers hope against multiresistant bacteria, including Staphylococcus aureus and Enterococcus faecium.

SourceWiley·DateOct 12, 2006

Controlling antibiotics and antibiotic resistance in hospitals

A study by Indiana University researchers found that hospitals implementing specific measures to control antibiotic use were more likely to succeed in controlling antibiotic resistance. Measures such as limiting broad-spectrum drug availability and restricting formularies were associated with lower rates of antibiotic resistance.

SourceIndiana University·JournalInfection Control and Hospital Epidemiology·DateOct 9, 2006

Antibiotic inhibits cancer gene activity

Researchers at the University of Illinois Chicago have identified an antibiotic that specifically targets the FoxM1 gene, which is responsible for cancer cell proliferation. The antibiotic, siomycin A, was found to induce cancer cells to commit suicide in a process called apoptosis, with no effect on normal cells.

SourceUniversity of Illinois Chicago·JournalCancer Research·DateOct 1, 2006

Is Clostridium difficile-associated disease linked to use of common stomach medication?

A recent study found a possible link between the use of proton pump inhibitors and an increased risk of community-acquired Clostridium difficile-associated disease. The research, published in the Canadian Medical Association Journal, suggests that patients who have been prescribed these medications may be more likely to develop CDAD.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateSep 25, 2006